Health Canada
- Status: approved
Individualization of first voriconazole maintenance doses (Individualization of first voriconazole maintenance doses) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
University Hospital, Grenoble is the originator. The local marketing authorisation holder may differ — check the official source linked above.